Cargando…
Retracted: Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma
Autor principal: | Markers, Disease |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307472/ https://www.ncbi.nlm.nih.gov/pubmed/37387763 http://dx.doi.org/10.1155/2023/9826032 |
Ejemplares similares
-
Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma
por: Ji, Xiang, et al.
Publicado: (2022) -
Retracted: Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma
por: Markers, Disease
Publicado: (2023) -
Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma
por: Markers, Disease
Publicado: (2023) -
Retracted: Anesthetic Effect of Dexmedetomidine in Clinical Functional Neurosurgery
por: Markers, Disease
Publicado: (2023) -
Retracted: Effects of Infrared Combined with Methylcobalamin on the Vibratory Sensory Threshold and Nerve Conduction Velocity of the Lower Extremity in Patients with Diabetic Foot Treatment
por: Markers, Disease
Publicado: (2023)